It is with pleasure that I am sharing with you our newest, peer-reviewed publication in the esteemed journal ‘’Journal of Clinical Medicine’’ (MDPI). Its title: ‘’Evidence on Serum Anti-Mullerian Hormone Levels and Endometriosis Surgery’’, a collaboration between a team of scientists and authors from various countries. The work is a review of the available literature on the topic.
Endometriosis is a benign disease of unknown aetiology, commonly associated with pelvic pain and infertility. Anti-mullerian hormone (AMH) is produced by the granulosa cells of the ovary and plays a regulatory role in folliculogenesis. AMH levels in the blood serum are believed to accurately reflect the ovarian reserve, with no significant variations during the menstrual cycle, making it a useful marker in daily clinical practice. However, AMH levels are not useful in predicting the chances of spontaneous (natural) conception.
While there is a link between endometriosis and infertility, there is conflicting evidence regarding the potential impact of various endometriosis phenotypes on serum AMH levels. Regarding the effect of endometriosis surgery on AMH values, the majority of the published literature focuses on patients with OMA, raising concerns regarding a potentially harmful effect of surgery on the ovarian reserve. Furthermore, identifying the precise clinical significance of serum AMH levels pre- and post-surgery in terms of predicting the probability of pregnancy would be most useful in patients with endometriosis and pregnancy intention.
You can read the full text of our publication, for free, in the following link: https://www.mdpi.com/2077-0383/14/11/3772
Congratulations to all co-authors for the hard work!
I do hope you all enjoy reading our new research and find it useful, whether you are a clinician, a patient or just interested in endometriosis care.